ACER · Categories · Form 4

ACER - SEC Form 4 insider transactions

Acer Therapeutics Inc. (ACER) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ACER

• 931d
  Aselage Steve returned 483,741 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 931d
  Dunn John Michael returned 27,380 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 931d
  Joseph Donald returned 14,285 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 931d
  Schelling Chris returned 2,712,529 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 931d
  Palmin Harry S returned 125,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 931d
  Davis Jefferson E returned 71,645 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1180d
  SEC Form 4 filed by Quartel Adrian W

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1180d
  SEC Form 4 filed by Paul Bernard H

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1180d
  SEC Form 4 filed by Palmin Harry S

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1180d
  SEC Form 4 filed by Klopp John Michael

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1180d
  SEC Form 4 filed by Joseph Donald

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1180d
  SEC Form 4 filed by Hayden Tanya

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1180d
  SEC Form 4 filed by Griffin Michelle Renee

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1180d
  SEC Form 4 filed by Dunn John Michael

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1180d
  SEC Form 4 filed by Davis Jefferson E

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1180d
  SEC Form 4 filed by Aselage Steve

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1180d
  SEC Form 4 filed by Amello Jason

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1285d
  SEC Form 4: Schelling Chris bought $1,000,000 worth of shares (819,672 units at $1.22), increasing direct ownership by 43% to 2,712,529 units

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1285d
  SEC Form 4: Aselage Steve bought $500,000 worth of shares (409,836 units at $1.22), increasing direct ownership by 555% to 483,741 units

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1447d
  SEC Form 4 filed by Hayden Tanya

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1566d
  SEC Form 4 filed by Quartel Adrian W

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1599d
  SEC Form 4 filed by Paul Bernard H

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1601d
  SEC Form 4 filed by Seibt Matthew

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1601d
  SEC Form 4 filed by Schelling Chris

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1601d
  SEC Form 4 filed by Palmin Harry S

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1601d
  SEC Form 4 filed by Klopp John Michael

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1601d
  SEC Form 4 filed by Joseph Donald

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1601d
  SEC Form 4 filed by Griffin Michelle Renee

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1601d
  SEC Form 4 filed by Dunn John Michael

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1601d
  SEC Form 4 filed by Davis Jefferson E

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1601d
  SEC Form 4 filed by Aselage Steve

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1601d
  SEC Form 4 filed by Amello Jason

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1638d
  SEC Form 4: Aselage Steve bought $20,622 worth of shares (10,000 units at $2.06), increasing direct ownership by 16% to 73,905 units

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1949d
  SEC Form 4 filed by E Jefferson Davis

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1965d
  SEC Form 4 filed by Matthew Seibt

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1965d
  SEC Form 4 filed by Chris Schelling

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1965d
  SEC Form 4 filed by S Harry Palmin

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1965d
  SEC Form 4 filed by Michael John Klopp

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1965d
  SEC Form 4 filed by Donald Joseph

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1965d
  SEC Form 4 filed by Renee Michelle Griffin

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1965d
  SEC Form 4 filed by Michael John Dunn

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1965d
  SEC Form 4 filed by Steve Aselage

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)
• 1965d
  SEC Form 4 filed by Jason Amello

  4 - Acer Therapeutics Inc. (0001069308) (Issuer)

Other ACER categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends